Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weiyu Ye

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
British Journal of Cancer|March 16, 2021
Checkpoint-blocker-induced autoimmunity is associated with favourable outcome in metastatic melanoma and distinct T-cell expression profilesWeiyu Ye, Anna Olsson-Brown, Robert A Watson, et al.
Journal for Immunotherapy of Cancer|April 25, 2024
Severe acute myositis and myocarditis on initiation of 6-weekly pembrolizumab post-COVID-19 mRNA vaccinationRobert A Watson, Weiyu Ye, Chelsea A Taylor, et al.
BMJ Open|October 10, 2025
PLAN-psoriasis: protocol for a randomised controlled feasibility trial comparing patient-led 'as-needed' treatment and therapeutic drug monitoring-guided treatment to continuous treatment for adults with clear or almost clear skin on risankizumab monotherapy for psoriasisWeiyu Ye, Kingsley Powell, Niamh Dooley, et al.
Nature Medicine|December 16, 2022
IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanomaChelsea A Taylor, Robert A Watson, Orion Tong, et al.
Nature Medicine|April 24, 2025
CMV serostatus is associated with improved survival and delayed toxicity onset following anti-PD-1 checkpoint blockadeGusztav Milotay, Martin Little, Robert A Watson, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
British Journal of Cancer|March 16, 2021
Checkpoint-blocker-induced autoimmunity is associated with favourable outcome in metastatic melanoma and distinct T-cell expression profilesWeiyu Ye, Anna Olsson-Brown, Robert A Watson, et al.
Journal for Immunotherapy of Cancer|April 25, 2024
Severe acute myositis and myocarditis on initiation of 6-weekly pembrolizumab post-COVID-19 mRNA vaccinationRobert A Watson, Weiyu Ye, Chelsea A Taylor, et al.
BMJ Open|October 10, 2025
PLAN-psoriasis: protocol for a randomised controlled feasibility trial comparing patient-led 'as-needed' treatment and therapeutic drug monitoring-guided treatment to continuous treatment for adults with clear or almost clear skin on risankizumab monotherapy for psoriasisWeiyu Ye, Kingsley Powell, Niamh Dooley, et al.
Nature Medicine|December 16, 2022
IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanomaChelsea A Taylor, Robert A Watson, Orion Tong, et al.
Nature Medicine|April 24, 2025
CMV serostatus is associated with improved survival and delayed toxicity onset following anti-PD-1 checkpoint blockadeGusztav Milotay, Martin Little, Robert A Watson, et al.
Pageof 2